ciprofloxacin has been researched along with amoxicillin-potassium clavulanate combination in 144 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (4.17) | 18.7374 |
1990's | 24 (16.67) | 18.2507 |
2000's | 41 (28.47) | 29.6817 |
2010's | 57 (39.58) | 24.3611 |
2020's | 16 (11.11) | 2.80 |
Authors | Studies |
---|---|
Beghi, G; Caratozzolo, O; Legnani, D; Lombardo, VM; Negretto, GG | 1 |
Altay, G; Cokça, F | 1 |
Gentry, LO | 1 |
Cherubin, CE; Eng, RH; Smith, SM; Tan, EN | 1 |
Lamb, YJ; Tehan, S | 1 |
Ritzerfeld, W; Schmidt, EW; Ulmer, WT; Voss, E; Zimmermann, I | 1 |
Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B | 1 |
Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
Crokaert, F; Glupczynski, Y; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Citron, DM; Goldstein, EJ | 1 |
Cellesi, C; Mencarelli, M; Rossolini, A; Sansoni, A; Zanchi, A | 1 |
Beauvillain, C; Berche, P; Bordure, P; Legent, F | 2 |
Bodey, G; Gikas, A; Maraki, S; Samonis, G; Toloudis, P; Tsaparas, N; Tselentis, Y; Vrentzos, G | 1 |
Beghi, GF; Casalini, A; Cazzola, M; Consigli, GF; Fiorentini, F; Giura, R; Madonini, V; Paizis, G; Tonna, M; Vinciguerra, A | 1 |
Davies, BI; Dirks-Go, SI; Hoogkamp-Korstanje, JA; Kabel, P; Manson, WL; Stobberingh, EE; Vreede, RW | 1 |
Gerbes, AL | 1 |
Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Joseph, EM; Sperling, NM | 1 |
Amyes, SG; Cakir, N; Gülay, Z; Mehr, MA; Yüce, A; Yulug, N | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
Fontanel, JP | 1 |
Belousov, IuB; Efremenkova, OV; Komarova, VP | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Andreu, M; Coll, S; Gana, J; Guarner, C; Miñana, J; Mirelis, B; Novella, MT; Ortiz, J; Prats, G; Sábat, M; Solá, R; Soriano, G; Vila, MC | 1 |
Berrisoul, F; Kearsley, N; Kubin, R; Kuss, A; Read, RC; Torres, A | 1 |
Charbit, Y; Fosse, TB; Hannoun, LR; Hitzig, C; Madinier, IM | 1 |
Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
Butkevich, OM; Vinogradova, TL | 1 |
Dunstan, FD; Fitzgerald, KA; Howard, AJ; Magee, JT | 1 |
Mizen, L | 1 |
Barbosa, FC; Cai, S; Mayer, MP; Saba-Chujfi, E | 1 |
Zaidi, SA | 1 |
Beaman, BL; Holodniy, M; Johnson, F; Lopez, FA; Novosad, DM | 1 |
Bernatoniene, G; Kaltenis, P; Murauskaite, G | 1 |
Cometta, A; Kern, W | 1 |
Goto, K; Kakinuma, R; Kubota, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H | 1 |
Alexopoulos, CG; Aoun, M; Cherifi, S; Klastersky, J; Lalami, Y; Munoz-Bermeo, R; Paesmans, M; Reuss, K | 1 |
Chadha, R; Jain, DV; Kashid, N | 1 |
Degener, JE; Gans, RO; Haaijer-Ruskamp, FM; Laseur, M; Mol, PG; Nannanpanday, PV; Wieringa, JE | 1 |
Gupta, K; Hooton, TM; Roberts, PL; Scholes, D; Stamm, WE; Stapleton, AE | 1 |
Borrows, R; Cairns, T; Chusney, G; Griffith, M; Hakim, N; James, A; McLean, A; Palmer, A; Papalois, V; Stichbury, J; Taube, D; Van Tromp, J | 1 |
Falagas, ME; Fragoulis, KN; Klouvas, GD | 1 |
Knerlich, F; Verheggen, R | 1 |
Amblar, G; Fernández-Cuenca, F; Martínez-Martínez, L; Pascual, A | 1 |
Abbas, AM; Chandra, V; Dongaonkar, PP; Goel, PK; Kacker, P; Patel, NA; Shrivastava, OP; Thakkar, B; Tillotson, GS | 1 |
Cardinale, E; Mead, G; Perrier Gros-Claude, JD; Rivoal, K; Rose, V; Salvat, G; Tall, F | 1 |
Bassoul, B; Causse, L; Dareau, S; Delire, V; Eledjam, JJ; Gros, T; Javitary, W | 1 |
Taylor, G; Vaile, L; Waddell, A; Williamson, T | 1 |
Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM | 1 |
Blasco Huelva, A; Carrasco Claver, F; González Palomino, A; Pantoja Hernández, CG; Pardo Romero, G; Pino Rivero, V; Trinidad Ramos, G | 1 |
Aw, LT; Ooi, EE; Sim, SH; Sivalingam, SP | 1 |
Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
Patel, SM; Saravolatz, LD | 1 |
Courtier, R; Gil, MJ; Grandea, L; Parés, D; Peláez, N; Pera, M; Sánchez, J | 1 |
de Cueto, M; Hernández, JR; López-Cerero, L; Morillo, C; Pascual, A | 1 |
Eder, W; Häussinger, K; Hoffmann, H; King, B; Markus, A; Morresi-Hauff, A; Philipp, E; Steffen, H; Weber, N; Wegerle, S | 1 |
Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
Anderson, G; Call, V; Foley, SL; Kaldhone, P; Kerdahi, K; Nayak, R; Phillips, S; Tyler, C | 1 |
Ballesta, S; Pascual, A; Rodríguez-Martínez, JM | 1 |
Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD | 1 |
Braña Rodríguez, A; Fonseca Aizpurua, EM; García Piney, E; Nuño Mateo, FJ | 1 |
Chazan, B; Colodner, R; Elias, M; Raz, R; Rock, W | 1 |
Balba, G; Kelesidis, T; Worthington, M | 1 |
Bergogne-Bérézin, E | 1 |
Bingen, E | 1 |
Arai, K; Hasegawa, M; Hatta, M; Hirakata, Y; Jones, RN; Kaku, M; Kawakami, K; Kitagawa, M; Kobayashi, I; Kohno, S; Kunishima, H; Matsuzaki, K; Mikuriya, M; Ohmori, K; Saika, T; Yamaguchi, K; Yamamoto, N; Yano, H | 1 |
Alonso, S; Courtier, R; Gil, MJ; Grande, L; Parés, D; Pascual, M; Pera, M | 1 |
Ardila, CM; Fernández, N; Guzmán, IC | 1 |
Cliby, WA; Diehl, CL; El-Nashar, SA; Famuyide, AO; Stanhope, CR; Swanson, CL; Thompson, RL | 1 |
Balogun-Ojuri, B; Hori, S; Joannides, A; McLoughlin, J; Sengupta, A; Tilley, R | 1 |
Battikh, R; Ben Abdelhafidh, N; Bougrine, F; Bouziani, A; M'Sadek, F; Madhi, W; Othmani, S; Yedeas, M | 1 |
Del Prado, G; Naves, P; Ponte, C; Soriano, F | 1 |
Aliyu, SH; Doble, A; Madden, T; Neal, DE | 1 |
Grable, I; Kasibowska-Kuźniar, K; Kuźniar, TJ | 1 |
Alvela-Suárez, L; Belhassen-Garcia, M; Carpio-Pérez, A; Fraile-Alonso, Mdel C; Pardo-Lledias, J; Velasco-Tirado, V | 1 |
Chung, H; Hoshide, RR; Tokeshi, J | 1 |
Ahmad, S; Cullen, IM; Fennell, JP; Flynn, R; Grainger, R; Manecksha, RP; McCullagh, E; McDermott, TE; Murphy, P; O'Kelly, F; Thornhill, JA | 1 |
Haith, K; Olson, RP | 1 |
Diogenes, A; Ferraz, CC; Ruparel, NB; Teixeira, FB | 1 |
Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
Alcalde-Vargas, A; De-la-Cruz-Ramírez, D; Herrera-Justiniano, JM; Leo Carnerero, E; Trigo-Salado, C | 1 |
Iordanishvili, AK; Muzykin, MI; Okovityĭ, SV | 1 |
Bearden, DT; Elman, MR; McGregor, JC; Smith, DH | 1 |
Goldfarb, DM; Mokomane, M; Narasimhamurthy, M; Renuart, AJ; Silverman, JA; Steenhoff, AP; Tawanana, EO | 1 |
Isaacs, J; Pullan, RD; Whelan-Johnson, S | 1 |
Hammert, WC; Richardson, WL | 1 |
Blackmore, T; Losco, G; Studd, R | 1 |
Chheda, NN; Duckworth, LV; Jaworek, AJ; Patel, S; Patel, V; Sawhney, R | 1 |
Fahal, AH; Mahgoub, el S; Mhmoud, NA; van de Sande, WW | 1 |
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
Alibay, A; Antoun, S; Borget, I; Chachaty, E; Di Palma, M; Gachot, B; Merad, M | 1 |
Chakravarthy, H; Lingaiah, BB; Madappa, BP; Raja, V; Subramani, P | 1 |
Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Brair, A; Gray, J; Toozs-Hobson, P | 1 |
Casas, M; Dalmau, B; Miquel, M; Moreno, L; Sánchez-Delgado, J; Vergara, M | 1 |
Ambeba, EJ; Cooper, JN; Deans, KJ; Lodwick, DL; Mahida, JB; Minneci, PC; Moss, RL; Nacion, KM; Sulkowski, JP | 1 |
Choe, HS; Kim, HY; Lee, DS; Lee, SJ; Yoo, JM | 1 |
Bryce, A; Costelloe, C; Hay, AD; Lane, IF; Thornton, HV; Wootton, M | 1 |
Russell, G | 1 |
Bakhsh, AR; Elrggal, ME; Faidah, HS; Haseeb, A; Hassali, MA; Khan, TM; Malki, WH; Rahman, SU; Saleem, F | 1 |
Guneysel, O; Ozturk, TC; Suman, E | 1 |
Bae, SR; Bae, WJ; Cho, YH; Choe, HS; Han, CH; Jang, H; Kim, HY; Kim, SW; Lee, DS; Lee, SJ; Park, SB; Yoo, JM; Yoon, BI | 1 |
Gancarčíková, S; Hrčková, G; Maďar, M; Mudroňová, D; Nemcová, R; Popper, M | 1 |
Lee, JS; Pan, JY; Tan, M | 1 |
Taylor, GJ; Vaile, L; Waddell, A; Williamson, T | 1 |
Harada, K; Shimizu, T | 1 |
Steurer, J | 1 |
Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
Charfeddine, I; Ghorbel, A; Maalej, F; Masmoudi, M; Mnejja, M; Sellami, M | 1 |
Bottieau, E; Hallin, M; Jacobs, J; Maniewski, U; Martiny, D; Ombelet, S; Post, A; Van Esbroeck, M; van Waterschoot, N; Vandenberg, O; Vlieghe, E | 1 |
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A | 1 |
Almirante, B; Andreu, A; Bosch-Nicolau, P; Falcó, V; Len, O; Pigrau, C; Viñado, B | 1 |
Barry, L; Corcoran, GD; Hooton, C; Lucey, B; O'Grady, MC; O'Halloran, C; Walsh, N | 1 |
Drago, F; Javor, S; Parodi, A | 1 |
AlSaeed, T; Fouad, AF; Melo, MA; Nosrat, A; Romberg, E; Wang, P; Xu, H | 1 |
Adebiyi, OR; Olorunsogo, OO; Oyebode, OT | 1 |
Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
Kurz, X; McGettigan, P; Morales, D; Pacurariu, A; Pinheiro, L; Slattery, J | 1 |
Amato, PS; Carlucci, E; Carro, GV; Dicatarina Losada, MV; Gette, F; Llanos, MLA; Noli, ML; Priore, G | 1 |
Bishop, B; Boyd, M; Craft, W; Marshall, KR; Santoro, D; Walton, SA; Wellehan, J | 1 |
Escrig Sos, J; Gil Fortuño, M; Granel Villach, L; Igual Adell, R; Martínez Ramos, D; Moreno Muñoz, R; Sabater Vidal, S; Soria Martín, R | 1 |
Díaz Barrón, A; Duch-Samper, AM; Hervás Hernandis, JM; Sanz Gallen, L; Tarragó Simón, E | 1 |
Busch, M; Jong, MC; Pot, G; van Oostveen, A; van Wietmarschen, HA | 1 |
Adams, R; Agus, A; Barnes, RA; Chau, I; Clarke, M; Coyle, V; Doran, A; Forde, C; Grayson, M; McAuley, DF; McDowell, C; McMullan, R; Plummer, R; Thomas, AL; Wilson, RH | 1 |
Begbey, A; Guppy, JH; Mohan, C; Webster, S | 1 |
Andriantahina, I; Angoulvant, F; Birgy, A; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; De Pontual, L; Dommergues, MA; Dubos, F; Gajdos, V; Georget, E; Gillet, Y; Grimprel, E; Jung, C; Launay, E; Levy, C; Lignieres, G; Madhi, F; Pinquier, D; Rybak, A; Soussan-Banini, V; Vignaud, O | 1 |
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
Becerra, AZ; Gulack, BC; Madonna, MB; Pillai, S; Shah, AN; Skertich, NJ; Sullivan, GA; Wiegmann, AL | 1 |
Crawford, SB; Davis, WH; Geno, KA; Magee, MR; Monks, SM | 1 |
Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
Bower, WA; Bulitta, JB; Chatham-Stephens, K; Cook, R; Hendricks, K; Kennedy, JL; Mongkolrattanothai, T; Negron, ME; Person, MK; Shin, E; Yu, P | 1 |
Attin, T; Bensland, S; Eick, S; Karygianni, L; Kulik, EM; Thurnheer, T | 1 |
Arezzo, A; Bonomo, LD; Ferguglia, A; Mingrone, G; Morino, M; Nicotera, A; Olandese, F; Pentassuglia, G; Veglia, S | 1 |
Chacko, S; Maheshwari, TK; Murdeshwar, S; Sheikh, RY | 1 |
Denny, JC; Forest, K; Gu, S; Larson, EA; Rajendiran, G; Tran, TC; Wilke, RA | 1 |
Cheng, WH; Ho, CH; Su, PY | 1 |
Durai, P; Goh, JC; Koh, SWC; Loh, VWK; Low, SH; Ng, TSM; Sun, LJ; Tambyah, PA; Tan, WZ; Wong, HC; Young, D | 1 |
11 review(s) available for ciprofloxacin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Humans; Ofloxacin; Prodrugs; Skin Diseases, Infectious | 1992 |
Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cardiomyopathy, Dilated; Ceftriaxone; Ciprofloxacin; Drug Resistance; Heart Transplantation; Humans; Male; Middle Aged; Nocardia; Nocardia Infections; Outcome Assessment, Health Care; Postoperative Complications; Sulfonamides | 2003 |
[Treatment with oral antibiotics of febrile neutropenia in onco-haematology. The experience of the EORTC antimicrobial group].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Europe; Fever; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Inpatients; Multicenter Studies as Topic; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; United States | 2004 |
Interventions for ear discharge associated with grommets (ventilation tubes).
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cerebrospinal Fluid Otorrhea; Child; Ciprofloxacin; Dexamethasone; Drug Combinations; Humans; Hydrocortisone; Middle Ear Ventilation; Neomycin; Otitis Media, Suppurative; Polymyxin B; Randomized Controlled Trials as Topic; Tympanic Membrane Perforation | 2006 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulitis; Cephalosporins; Ciprofloxacin; Diverticulitis; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Meningitis, Bacterial; Neutropenia; Osteomyelitis; Pneumonia; Staphylococcus aureus; Viridans Streptococci | 2006 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
[Lower urinary tract infections: bacterial epidemiology and recommendations].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; Time Factors; Urinary Tract Infections | 2008 |
Adverse effects of common oral antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Ciprofloxacin; Clindamycin; Hand; Hand Dermatoses; Humans; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Observational Studies as Topic; Prevalence; Primary Health Care; Urinary Tract Infections | 2016 |
WITHDRAWN: Interventions for ear discharge associated with grommets (ventilation tubes).
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cerebrospinal Fluid Otorrhea; Child; Ciprofloxacin; Dexamethasone; Drug Combinations; Humans; Hydrocortisone; Middle Ear Ventilation; Neomycin; Otitis Media, Suppurative; Polymyxin B; Randomized Controlled Trials as Topic; Tympanic Membrane Perforation | 2016 |
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; beta-Lactams; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Doxycycline; Glycopeptides; Humans; Levofloxacin; Lipopeptides; Models, Animal; Tetracyclines; United States | 2022 |
16 trial(s) available for ciprofloxacin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Female; Histamine; Humans; Male; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Function Tests; Sputum | 1989 |
Controlled prospective study of oral ciprofloxacin versus amoxycillin/clavulanic acid in chronic suppurative otitis media in adults.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Otitis Media, Suppurative; Pseudomonas Infections; Time Factors | 1994 |
A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Ethmoid Sinusitis; Female; Frontal Sinusitis; Humans; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Sinusitis | 1994 |
Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1995 |
[Antibiotic prophylaxis after gastrointestinal hemorrhage in liver cirrhosis--for which patients, with what antibiotics?].
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Critical Care; Dose-Response Relationship, Drug; Drug Administration Schedule; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Opportunistic Infections; Risk Factors; Survival Rate | 1997 |
[Selection of antibacterial therapy for treatment of infections in elderly patients].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections | 1998 |
The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Tablets; Treatment Outcome | 1999 |
Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
Topics: Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 2004 |
A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Ciprofloxacin; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Male; Middle Aged; Neutropenia; Prospective Studies | 2004 |
Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cystitis; Escherichia coli; Female; Humans; Single-Blind Method; Vagina | 2005 |
Determinants of mycophenolic acid levels after renal transplantation.
Topics: Adult; Alanine Transaminase; Amoxicillin-Potassium Clavulanate Combination; Biomarkers; Ciprofloxacin; Creatinine; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Metronidazole; Middle Aged; Mycophenolic Acid; Prodrugs; Serum Albumin; Tacrolimus; Time Factors; Treatment Outcome | 2005 |
Outpatient treatment of patients with uncomplicated acute diverticulitis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diverticulitis; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antifungal Agents; Child; Ciprofloxacin; Coinfection; Drug Therapy, Combination; Female; Humans; Ketoconazole; Madurella; Male; Middle Aged; Mycetoma; Prospective Studies; Staphylococcal Infections; Treatment Outcome; Young Adult | 2014 |
Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Ciprofloxacin; Conservative Treatment; Diverticulitis, Colonic; Drug Administration Schedule; Drug Hypersensitivity; Drug Substitution; Female; Guideline Adherence; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Netherlands; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Probiotics use for antibiotic-associated diarrhea: a pragmatic participatory evaluation in nursing homes.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Female; Homes for the Aged; Humans; Male; Netherlands; Nursing Homes; Probiotics; Treatment Outcome | 2020 |
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cost-Benefit Analysis; Drug Administration Schedule; Equivalence Trials as Topic; Humans; Meropenem; Multicenter Studies as Topic; Neoplasms; Neutropenia; Piperacillin; Pragmatic Clinical Trials as Topic; Quality of Life; Sepsis; Tazobactam; Treatment Outcome | 2020 |
117 other study(ies) available for ciprofloxacin and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Comparative clinical and microbiological study of amoxycillin-clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies | 1992 |
[Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Serial Passage; Staphylococcus aureus; Vancomycin | 1992 |
A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Conformation; Ofloxacin; Respiratory System; Respiratory Tract Infections; Sputum | 1992 |
Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Family Practice; Humans; Urinary Tract Infections | 1990 |
The effect of anaerobiosis on antistaphylococcal antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin | 1988 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
Rate of bactericidal activity for Branhamella catarrhalis of fleroxacin compared with that of amoxycillin-clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Fleroxacin; Microbial Sensitivity Tests; Moraxella catarrhalis | 1988 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Bites and Stings; Bites, Human; Cats; Cefuroxime; Cephalosporins; Ciprofloxacin; Clavulanic Acids; Dogs; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Wound Infection | 1988 |
Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Italy; Serotyping | 1994 |
Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Candida; Ciprofloxacin; Clavulanic Acids; Feces; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Quinolones; Streptococcus pneumoniae | 1997 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Audiometry; Bone Conduction; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Facial Paralysis; Female; Follow-Up Studies; Glucocorticoids; Hearing Loss; Hearing Loss, Conductive; Humans; Male; Middle Aged; Otitis Media; Penicillins; Prednisone; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1998 |
Transferable trimethoprim resistance in Shigella strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Conjugation, Genetic; Drug Therapy, Combination; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Plasmids; Shigella; Trimethoprim; Trimethoprim Resistance | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
[Role of ciprofloxacin in the treatment of chronic otitis media].
Topics: Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Cholesteatoma, Middle Ear; Chronic Disease; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Otitis Media; Otitis Media with Effusion; Prospective Studies; Time Factors | 1998 |
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella | 1998 |
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Ofloxacin; Time Factors; Treatment Outcome | 1999 |
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Pocket; Periodontitis; Species Specificity; Spiramycin; Tetracycline; Virginiamycin | 1999 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cephalexin; Cephradine; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim; Urinary Tract Infections | 2001 |
The activity of antibiotics against Legionella pneumophila: in vitro and in vivo studies.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Ciprofloxacin; Humans; Legionella pneumophila; Legionnaires' Disease | 2001 |
Subgingival occurrence and antimicrobial susceptibility of enteric rods and pseudomonads from Brazilian periodontitis patients.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Brazil; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Enterobacteriaceae; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Pseudomonas | 2001 |
Hepatitis associated with amoxicillin/clavulanic acid and/or ciprofloxacin.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Amoxicillin-Potassium Clavulanate Combination; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Humans; Male | 2003 |
[Urinary microflora in children from different pediatric departments].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Escherichia coli; Gentamicins; Humans; Inpatients; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Staphylococcus aureus; Urine | 2003 |
Microcalorimetric evaluation of the in vitro compatibility of amoxicillin/clavulanic acid and ampicillin/sulbactam with ciprofloxacin.
Topics: Algorithms; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Buffers; Calorimetry; Ciprofloxacin; Drug Incompatibility; Drug Therapy, Combination; Hydrogen-Ion Concentration; Penicillins; Solutions; Sulbactam; Thermodynamics | 2004 |
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Prescriptions; Drug Utilization Review; Guideline Adherence; Hospitals, University; Humans; Medical Staff, Hospital; Netherlands; Practice Guidelines as Topic; Program Evaluation; Time Factors | 2005 |
[Bacterial infections in cancer patients].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Ciprofloxacin; Humans; Immune Tolerance; Neoplasms; Opportunistic Infections; Practice Guidelines as Topic; Pseudomonas Infections | 2005 |
Cipro bests Augmentin in bladder infection treatment.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Cystitis; Female; Humans | 2005 |
Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Facial Dermatoses; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Skin Diseases, Bacterial | 2005 |
Neurological picture. Feeding cats might be dangerous: penetrating orbital and brain injury without neurological deficits.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Animals; Antifungal Agents; Brain Injuries; Cats; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Female; Food; Humans; Magnetic Resonance Imaging; Metronidazole; Microsurgery; Neurosurgical Procedures; Orbit; Postoperative Care; Risk-Taking; Severity of Illness Index; Tomography, X-Ray Computed; Wounds, Penetrating; Wounds, Stab | 2005 |
[Relationships between resistance to cefoxitin, ciprofloxacin and amoxicillin-clavulanic acid in Escherichia coli clinical isolates].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Spain | 2005 |
Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Family Practice; Female; Humans; Male; Treatment Outcome; Urinary Tract Infections | 1989 |
Genetic characterization and antibiotic resistance of Campylobacter spp. isolated from poultry and humans in Senegal.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Food Microbiology; Genes, Bacterial; Genetic Variation; Genotype; Humans; Nalidixic Acid; Poultry; Quinolones | 2006 |
[Postoperative pneumonia: nosocomial, predictable, iatrogenic, preventable or not?].
Topics: Alcoholism; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Carcinoma, Squamous Cell; Ciprofloxacin; Cross Infection; Disease Susceptibility; Fatal Outcome; Humans; Iatrogenic Disease; Immunocompromised Host; Liver Cirrhosis, Alcoholic; Male; Malnutrition; Malpractice; Middle Aged; Mouth; Neck Dissection; Neoplasm Recurrence, Local; Oxygen; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Tongue Neoplasms | 2006 |
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2006 |
[Parotid phlegmon with involvement of both lobes. Report of a case].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cellulitis; Ciprofloxacin; Dipyrone; Drug Therapy, Combination; Humans; Male; Methylprednisolone; Middle Aged; Omeprazole; Parotid Diseases; Pregnenediones; Severity of Illness Index; Tomography, X-Ray Computed | 2006 |
Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Ciprofloxacin; Doxycycline; Humans; Melioidosis; Microbial Sensitivity Tests; Singapore; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
[Applicability, safety and efficacy of an ambulatory treatment protocol in patients with uncomplicated acute diverticulitis].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Data Interpretation, Statistical; Diverticulitis; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Patient Selection; Prospective Studies; Radiography, Abdominal; Safety; Time Factors; Tomography, X-Ray Computed | 2006 |
[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Escherichia coli; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multicenter Studies as Topic; Substrate Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
[Pulmonary nocardiosis with trimethoprime/sulphamethoxazole-resistant Nocardia paucivorans in a patient with no signs of immunosuppression].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Pneumonia, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Indicator Dilution Techniques; Microbial Sensitivity Tests; Poultry; Quality Control; Salmonella enterica; Sulfamethizole; Tetracycline; Trimethoprim | 2007 |
Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Escherichia coli; Fosfomycin; Humans; Pseudomonas aeruginosa; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacterial Infections; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies | 2007 |
[Bite of a poisonous snake].
Topics: Adrenal Cortex Hormones; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antivenins; Ciprofloxacin; Colubridae; Female; Humans; Male; Middle Aged; Snake Bites; Snake Venoms; Spain; Tetanus Toxoid; Viperidae | 2007 |
Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents, Urinary; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Humans; Israel; Microbial Sensitivity Tests; Nitrofurantoin; Population Surveillance; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Axillary abscess in a patient with Yersinia enterocolitica infection as a result of exposure to pork.
Topics: Abscess; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Food Microbiology; Humans; Male; Meat; Middle Aged; Swine; Yersinia enterocolitica; Yersinia Infections | 2008 |
[Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria; beta-Lactamases; Cephalosporin Resistance; Cephalothin; Child; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Shigella sonnei; Staphylococcus aureus | 2008 |
Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone re
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Mutation | 2009 |
Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Chi-Square Distribution; Chronic Periodontitis; Ciprofloxacin; Colombia; Dental Plaque; Enterobacteriaceae; Female; Fluoroquinolones; Gram-Negative Facultatively Anaerobic Rods; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pseudomonas; Quinolines; Statistics, Nonparametric | 2010 |
Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Mass Index; Cefazolin; Ciprofloxacin; Cohort Studies; Drainage; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Obesity, Morbid; Ofloxacin; Retrospective Studies; Subcutaneous Fat, Abdominal; Surgical Wound Infection | 2010 |
Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk?
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Epidemiologic Methods; Humans; Male; Middle Aged; Penicillins; Prostate; Prostatic Neoplasms; Rectum; Treatment Outcome; Ultrasonography, Interventional | 2010 |
[Cerebral actinomycosis pseudotumor: a case report].
Topics: Actinomycosis; Adrenal Cortex Hormones; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Dental Caries; Drug Therapy, Combination; Dysarthria; Humans; Male; Metronidazole; Middle Aged; Occipital Lobe; Oral Hygiene; Paresis; Penicillin G; Periapical Abscess; Pseudotumor Cerebri; Seizures; Tomography, X-Ray Computed | 2011 |
Differences in the in vitro susceptibility of planktonic and biofilm-associated Escherichia coli strains to antimicrobial agents.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Oxazines; Plankton; Xanthenes | 2010 |
Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Clinical Protocols; Clostridioides difficile; Clostridium Infections; Cross Infection; Gentamicins; Humans; Male; Prostate; Ultrasonography, Interventional | 2011 |
Parotid abscess in a patient with obstructive sleep apnea treated with continuous positive airway pressure therapy.
Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Continuous Positive Airway Pressure; Disease Progression; Humans; Male; Masks; Parotid Diseases; Parotid Gland; Polysomnography; Pressure; Sialadenitis; Sleep Apnea, Obstructive; Streptococcal Infections; Streptococcus anginosus | 2012 |
Cavitary pneumonia and skin lesions.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Pneumonia, Bacterial; Skin Diseases, Bacterial; Tularemia | 2012 |
Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; beta-Lactamases; Ciprofloxacin; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Hawaii; Humans; Male; Meropenem; Middle Aged; Nitrofurantoin; Risk Factors; Thienamycins | 2011 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Incidence; Male; Microbial Sensitivity Tests; Nitrofurantoin; Prevalence; Retrospective Studies; Time Factors; Trimethoprim; Urinary Tract Infections | 2013 |
Antibiotic resistance in urinary tract infections in college students.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Nitrofurantoin; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Students; Universities; Urinary Tract Infections; Women's Health; Young Adult | 2012 |
Direct effect of intracanal medicaments on survival of stem cells of the apical papilla.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Calcium Hydroxide; Cefaclor; Cell Survival; Cells, Cultured; Ciprofloxacin; Dental Papilla; Dose-Response Relationship, Drug; Female; Humans; Metronidazole; Molar, Third; Root Canal Irrigants; Statistics, Nonparametric; Stem Cells | 2012 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Pseudomembranous colitis and bacteremia in an immune competent patient associated with a rare specie of Clostridium (C. ramosum).
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompetence; Metronidazole; Species Specificity; Ulcer | 2012 |
[The improvement of complex treatment of odontogenous periostitis in elderly patients].
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Jaw Diseases; Male; Middle Aged; Ofloxacin; Periostitis; Suppuration; Treatment Outcome | 2012 |
Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2013 |
Microbiology of urinary tract infections in Gaborone, Botswana.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Botswana; Ciprofloxacin; Comorbidity; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2013 |
Sacro-iliac osteomyelitis in a 13 year old boy following perforated appendicitis.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ascitic Fluid; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Humans; Laparotomy; Magnetic Resonance Imaging; Male; Metronidazole; Osteomyelitis; Rifampin; Rupture, Spontaneous; Sacroiliitis | 2013 |
Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Ertapenem; Escherichia coli Infections; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Rectum; Risk Assessment; Risk Factors; Sepsis; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Interventional | 2014 |
Laryngeal actinomycosis in an immunocompromised patient.
Topics: Actinomycosis; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Humans; Immunocompromised Host; Laryngeal Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
[Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
Topics: Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Agents; Cancer Care Facilities; Ceftriaxone; Ciprofloxacin; Emergency Service, Hospital; Febrile Neutropenia; Female; France; Hospitalization; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Assessment; Young Adult | 2014 |
Group G Streptococci in association with brain abscess: a rare occurrence.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Brain; Brain Abscess; Child; Ciprofloxacin; Female; Humans; Magnetic Resonance Imaging; Radiography; Streptococcal Infections; Streptococcus; Treatment Outcome | 2014 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clinical Audit; Drug Resistance, Bacterial; England; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Health Policy; Humans; Meropenem; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Thienamycins; Trimethoprim; Urinary Tract Infections | 2015 |
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Female; Humans; Middle Aged; Recurrence | 2015 |
Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Ciprofloxacin; Family; Female; Health Care Costs; Humans; Laparoscopy; Male; Metronidazole; Patient Participation; Patient Preference; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2016 |
Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Ciprofloxacin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Antibiotic resistance in children with E coli urinary tract infection.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Urinary Tract Infections | 2016 |
Antimicrobial resistance among pilgrims: a retrospective study from two hospitals in Makkah, Saudi Arabia.
Topics: Acinetobacter baumannii; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Hospitals; Humans; Klebsiella pneumoniae; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Saudi Arabia; Travel | 2016 |
TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES.
Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2016 |
Role of age and sex in determining antibiotic resistance in febrile urinary tract infections.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Humans; Incidence; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Retrospective Studies; Sex Factors; Urinary Tract Infections; Young Adult | 2016 |
Amoxicillin-clavulanic acid and ciprofloxacin-treated SPF mice as gnotobiotic model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cecum; Ciprofloxacin; Feces; Female; Germ-Free Life; Mice, Inbred BALB C; Models, Animal; Time Factors | 2016 |
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Coinfection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Male; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disease Eradication; Dog Diseases; Dogs; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2017 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
[The complicated acute bacterial parotitis in adults].
Topics: Acute Disease; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Female; Humans; Metronidazole; Parotitis; Self Medication; Streptococcal Infections; Tomography, X-Ray Computed; Viridans Streptococci | 2017 |
Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Child; Child, Preschool; Ciprofloxacin; Communicable Diseases, Imported; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Young Adult | 2017 |
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Empirical Research; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2017 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Cephradine; Ciprofloxacin; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2018 |
Case Report: Atypical Cutaneous Manifestations of Tularemia after Horsefly Bite.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Diagnosis, Differential; Diptera; Female; Francisella tularensis; Gentamicins; Humans; Immunoglobulin G; Immunoglobulin M; Insect Bites and Stings; Insect Vectors; Middle Aged; Tularemia; Zoonoses | 2018 |
Antibacterial Efficacy and Discoloration Potential of Endodontic Topical Antibiotics.
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Dental Pulp Cavity; Enterococcus faecalis; Fusobacterium nucleatum; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Metronidazole; Microbial Sensitivity Tests; Minocycline; Porphyromonas gingivalis; Regenerative Endodontics; Root Canal Therapy; Streptococcus intermedius; Tigecycline; Tissue Scaffolds; Tooth Discoloration | 2018 |
Toxicity of some broad-spectrum antibacterials in normal rat liver: the role of mitochondrial membrane permeability transition pore.
Topics: Adenosine Triphosphatases; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Caspase 3; Caspase 9; Ciprofloxacin; Cytochromes c; Dose-Response Relationship, Drug; Energy Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Rats, Wistar; Risk Assessment | 2019 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Female; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Moxifloxacin; Norfloxacin; Ofloxacin; Peripheral Nervous System Diseases; Risk Factors; Sex Factors; United Kingdom | 2019 |
[Infections in diabetic foot. Choice of empirical antibiotic regimen].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Wound Infection | 2019 |
Erysipeloid lesions caused by Erysipelothrix rhusiopathiae in a dog: clinical and histopathological findings, molecular diagnosis and treatment.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Dog Diseases; Dogs; Erysipeloid; Erysipelothrix; Female; Postoperative Complications | 2019 |
[Biliary microbiote in cholecystectomized patients: Review of empirical antibiotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bile; Cholecystectomy; Cholecystitis; Ciprofloxacin; Escherichia coli; Female; Gram-Negative Bacteria; Humans; Klebsiella; Male; Metronidazole; Microbial Sensitivity Tests; Microbiota; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult | 2019 |
Bacterial keratitis due to Moraxella nonliquefaciens.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Corneal Opacity; Corneal Ulcer; Drug Substitution; Eye Infections, Bacterial; Humans; Hyphema; Male; Moraxella; Moraxellaceae Infections; Vancomycin | 2020 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult | 2020 |
Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Topics: Administration, Oral; Adolescent; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Child; Child, Preschool; Ciprofloxacin; Enterobacteriaceae; Female; Fever; France; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Phenotype; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
A shortened course of Amoxicillin/Clavulanate is the preferred antibiotic treatment after surgery for perforated appendicitis in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Ciprofloxacin; Drug Therapy, Combination; Humans; Metronidazole; Retrospective Studies; Treatment Outcome | 2023 |
Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cefuroxime; Cephalexin; Ciprofloxacin; Emergency Service, Hospital; Fluoroquinolones; Humans; Levofloxacin; Mexico; Nitrofurantoin; Retrospective Studies; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Capnocytophaga; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Fusobacterium; Humans; Leptothrix; Leptotrichia; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases | 2023 |
Outcomes of surgical treatment of diverticular abscesses after failure of antibiotic therapy.
Topics: Abdominal Abscess; Abscess; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Colectomy; Diverticulitis, Colonic; Diverticulosis, Colonic; Drainage; Humans; Metronidazole; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2023 |
Microbiological Spectrum and Antibiogram of Urinary Tract Infection in a Tertiary Care Center from the Kingdom of Bahrain.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Carbapenems; Ciprofloxacin; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Levofloxacin; Male; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cephalexin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Humans; Population Health; Retrospective Studies; United States | 2023 |
Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefuroxime; Ciprofloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Nitrofurantoin; Primary Health Care; Retrospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2023 |